(Q55476192)

12 July 2018

editorial

0 references

title

Medulloblastoma--challenges in radiation therapy and the addition of chemotherapy. (English)

1 reference

12 July 2018

adaptive radiation therapy

main subject

0 references

medulloblastoma

0 references

author name string

Kun LE

series ordinal

1

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

12 July 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

12 July 2018

volume

46

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

261-263

1 reference

12 July 2018

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Postoperative radiotherapy of medulloblastoma. Impact of radiation quality on treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Pediatric medulloblastoma: radiation treatment technique and patterns of failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Chemoradiotherapy interactions in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

Medulloblastoma: time-dose relationship based on a 30-year review.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900368-5

7 January 2021

10.1016/S0360-3016(99)00368-5

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018